The Baldwin Insurance Group, Inc., known as The Baldwin Group (BWIN), operates as an independent insurance distribution firm serving more than three million clients. Its third quarter 2026 update comes at a unique moment because the company has agreed to an all-cash acquisition by Sequence Holdings and DFO Management at $32.50 per share. Given the pending go-private transaction, management released preliminary, unaudited figures instead of a standard earnings package. The focus for investors is whether core growth, profitability, and cash generation hold steady while the merger progresses toward completion. These numbers provide one last public snapshot of the business before it is expected to leave the Nasdaq.
For the quarter ended September 30, 2026, total revenue reached $480.3 million, marking a 31% increase from $365.4 million in the same period last year. Organic revenue growth came in at 6% year over year. The reported figure landed slightly below the roughly $492 million consensus estimate. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
GAAP net loss widened to $81.6 million from $30.2 million a year earlier, partly because of roughly $21 million in go-private and transaction-related expenses. Adjusted EBITDA rose 47% to $106.9 million, and the margin expanded to 22.2% from 19.8%. Net cash from operating activities was $54.2 million, while adjusted free cash flow grew 33% to $55.6 million. At quarter-end, cash and cash equivalents stood at $188.6 million, total debt at $2.465 billion, and available revolving credit at about $289.1 million.
Attention around BWIN centers more on the pending $32.50-per-share transaction than on the quarterly numbers themselves. The buyout price has become the key reference point, and the stock has traded close to that level while investors assess the odds of closing. The preliminary results confirmed solid top-line momentum and wider adjusted margins, yet the larger GAAP loss and one-time costs highlight the transitional phase. Sentiment stays tied to regulatory and shareholder approvals rather than near-term earnings, since the transaction is slated for the first quarter of 2027.
The primary catalyst remains completion of the all-cash merger. Progress on shareholder approval, regulatory clearance, and other standard closing conditions will determine whether the $32.50 payout materializes. Any delay or shift in terms could influence the share price.
Underlying business trends still warrant attention. The reported 6% organic revenue growth came with noted headwinds in the Medicare operation tied to plan changes and provider exits. Management indicated that normalizing for those effects would have produced higher organic growth. Adjusted EBITDA margin improvement to 22.2% and the 33% rise in adjusted free cash flow point to ongoing strength in the insurance distribution platform. Integration updates from recent partnerships and the CAC Group combination are secondary while the buyout drives value.
One tool I’ve found helpful lately is Tickeron’s AI Screener, which lets me quickly filter stocks by technical patterns, fundamentals, and performance metrics to compare opportunities across sectors. It streamlines the process of spotting ideas worth reviewing, especially during earnings season or when evaluating acquisition targets like this one. The platform has become a regular part of how I cross-check data points and industry context before forming a view.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
BWIN saw its Momentum Indicator move above the 0 level on October 30, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 83 similar instances where the indicator turned positive. In 63 of the 83 cases, the stock moved higher in the following days. The odds of a move higher are at 76%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 41 of 55 cases where BWIN's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 75%.
Following a +0.31% 3-day Advance, the price is estimated to grow further. Considering data from situations where BWIN advanced for three days, in 225 of 304 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BWIN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.
BWIN broke above its upper Bollinger Band on October 26, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Valuation Rating of 8 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.503) is normal, around the industry mean (2.673). BWIN has a moderately low P/E Ratio (-30.467) as compared to the industry average of (18.899). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (8.322). Dividend Yield (0.000) settles around the average of (0.042) among similar stocks. P/S Ratio (1.265) is also within normal values, averaging (2.968).
The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating steady price growth. BWIN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 72 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BWIN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry InsuranceBrokersServices